Literature DB >> 17244880

Projecting future drug expenditures--2007.

James M Hoffman1, Nilay D Shah, Lee C Vermeulen, Glen T Schumock, Penny Grim, Robert J Hunkler, Karrie M Hontz.   

Abstract

PURPOSE: Drug expenditure trends in 2005 and 2006, projected drug expenditures for 2007, and factors likely to influence drug costs are discussed.
SUMMARY: Various factors are likely to affect drug costs, including drug prices, drugs in development, and generic drugs. In 2005, there was a continued moderation of the increase in drug expenditures. Total prescription drug expenditures increased by 5.5% from 2004 to 2005, with total spending rising from $239 billion to $252 billion. Through the first nine months of 2006, hospital drug expenditures increased by only 3% compared with 2005. This moderation of the growth of prescription drug expenditures can be attributed to three major factors: availability of major prescription drugs in generic form, continued increase in cost sharing for employees in employer-sponsored health plans, and decreased use due to safety concerns. It is expected that expenditures in 2007 will be influenced by similar factors, with few costly new products reaching the market, increased concern over product safety reducing the use of older agents and slowing the diffusion of newer agents that do reach the market, and several important patent expirations, leading to slower growth in expenditures.
CONCLUSION: In 2007, we project a 5-7% increase in drug expenditures in outpatient settings, a 14-16% increase in clinics, and a 4-6% increase in hospitals.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17244880     DOI: 10.2146/ajhp060545

Source DB:  PubMed          Journal:  Am J Health Syst Pharm        ISSN: 1079-2082            Impact factor:   2.637


  6 in total

1.  Accuracy of annual prescription drug expenditure forecasts in AJHP.

Authors:  Patricia L Hartke; Lee C Vermeulen; James M Hoffman; Nilay D Shah; Fred Doloresco; Katie J Suda; Edward C Li; Linda M Matusiak; Robert J Hunkler; Glen T Schumock
Journal:  Am J Health Syst Pharm       Date:  2015-10-01       Impact factor: 2.637

2.  Antimicrobial stewardship in acute care centres: A survey of 68 hospitals in Quebec.

Authors:  Vincent Nault; Mathieu Beaudoin; Daniel Jg Thirion; Michel Gosselin; Benoit Cossette; Louis Valiquette
Journal:  Can J Infect Dis Med Microbiol       Date:  2008-05       Impact factor: 2.471

3.  Trends in pharmaceutical expenditures: the impact on drug benefit design.

Authors:  LaFleur Joanne; Fish Leslie; Diana I Brixner
Journal:  Am Health Drug Benefits       Date:  2008-05

4.  Financial Consequences of Improved Treatments for Colorectal Cancer.

Authors:  Yu-Ning Wong
Journal:  Semin Colon Rectal Surg       Date:  2008-12-01

5.  The effects of repeated zolpidem treatment on tolerance, withdrawal-like symptoms, and GABAA receptor mRNAs profile expression in mice: comparison with diazepam.

Authors:  Brittany T Wright; Catherine F Gluszek; Scott A Heldt
Journal:  Psychopharmacology (Berl)       Date:  2014-02-15       Impact factor: 4.530

Review 6.  Antibiotic stewardship program in dentistry: Challenges and opportunities.

Authors:  Saima Siddique; Kumar Gaurav Chhabra; Amit Reche; Priyanka Paul Madhu; Akansha Kunghadkar; Shivani Kalmegh
Journal:  J Family Med Prim Care       Date:  2021-11-29
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.